Mitomycin and BCG treatment vs BCG monotherapy in patients with non-muscle invasive bladder cancer

ASCO 2021: Precision and molecular reporting for prostate cancer

ALCSI: Raising lung cancer screening awareness in the US

Pembrolizumab plus trastuzumab and chemotherapy for HER2+ metastatic gastric or gastroesophageal junction cancer

Real world evidence on the use of antibody drug conjugates in peripheral T-cell lymphoma

Patritumab deruxtecan (HER3-DXd) in EGFR inhibitor-resistant, EGFR-mutated NSCLC

ELEVATE-TN: Acalabrutinib ± obinutuzumab versus obinutuzumab + chlorambucil in treatment-naïve CLL - Four-year follow up

IMpower010: Atezolizumab versus best supportive care after adjuvant chemotherapy in resected NSCLC

Clinically sufficient vitamin D levels at breast cancer diagnosis and survival outcomes

CAPTIVATE: Fixed-duration first-line treatment with ibrutinib plus venetoclax for CLL/SLL

CHRONOS: Anti-EGFR rechallenge therapy with panitumumab driven by ctDNA molecular selection in mCC

CodeBreaK100: Sotorasib in pretreated KRAS p.G12C mNSCLC